Today: 10 June 2026
Browse Category

NYSE:ORCL 30 November 2025 - 10 December 2025

US Stock Market Today: Futures Edge Higher as Fed Rate Cut, Wage Data and Big Tech Earnings Loom — What to Know Before the December 10, 2025 Open

US Stock Market Today: Futures Edge Higher as Fed Rate Cut, Wage Data and Big Tech Earnings Loom — What to Know Before the December 10, 2025 Open

U.S. stock futures edged higher early Wednesday ahead of the Federal Reserve’s final rate decision of 2025, with S&P 500 futures up 0.1%. Traders expect a quarter-point rate cut at 2 p.m. ET and are watching for signals on future policy. The 10-year Treasury yield hovered near 4.18%. JPMorgan Chase shares fell sharply Tuesday after warning of higher 2026 expenses.
10 December 2025
·····
Earnings to Watch Before and After the Bell on December 10, 2025: Oracle, Adobe, Synopsys, Chewy and More

Earnings to Watch Before and After the Bell on December 10, 2025: Oracle, Adobe, Synopsys, Chewy and More

Investors await the Federal Reserve’s decision and earnings from Oracle, Adobe, Synopsys, and Planet Labs, with markets volatile ahead of key AI results. Chewy, Uranium Energy, REV Group, Daktronics, VersaBank, and J. Jill report before the open. Chewy is expected to post a sharp year-on-year EPS swing. Options activity signals traders are bracing for large post-earnings moves in AI-linked stocks.
10 December 2025
···········
Oracle Stock (ORCL) Today: AI Backlog, Debt Jitters and Q2 FY 2026 Earnings Preview for December 9, 2025

Oracle Stock (ORCL) Today: AI Backlog, Debt Jitters and Q2 FY 2026 Earnings Preview for December 9, 2025

Oracle shares traded near $221 midday Monday, down about 36% from September’s record high after a surge driven by AI cloud deals. Q2 fiscal 2026 earnings are due after the close December 10, with Wall Street expecting $16.2 billion in revenue and $1.64 adjusted EPS. Options markets are pricing a roughly 11% swing on the results. The stock’s slide follows concerns over rising debt and heavy AI infrastructure spending.
9 December 2025
··
Stock Market Earnings Preview for December 8–15, 2025: Oracle, Broadcom, Costco and GameStop Lead a Fed‑Heavy Week

Stock Market Earnings Preview for December 8–15, 2025: Oracle, Broadcom, Costco and GameStop Lead a Fed‑Heavy Week

The Federal Reserve is expected to cut rates for a third straight time at its final meeting of 2025, with a decision due December 10. Major earnings reports from Oracle, Broadcom, Adobe, Costco, GameStop, and Lululemon are set for the week, raising the prospect of market volatility. Key economic data releases remain delayed after the fall government shutdown.
7 December 2025
···········
Oracle Corp (ORCL) Stock on December 6, 2025: AI Cloud Deals, Debt Risks and Q2 2026 Earnings Forecast

Oracle Corp (ORCL) Stock on December 6, 2025: AI Cloud Deals, Debt Risks and Q2 2026 Earnings Forecast

Oracle shares closed at $217.58 Friday, up 1.5% and marking a fourth straight day of gains, but remain about 37% below their September high of $345.72. Trading volume topped 24 million shares, above the 50-day average. Fiscal Q2 2026 earnings are due December 10, with Wall Street expecting EPS between $1.50 and $1.63 and revenue near $16.2 billion.
6 December 2025
····
Oracle vs Amazon Stock: Which AI Cloud Giant Looks Better Positioned for 2026?

Oracle vs Amazon Stock: Which AI Cloud Giant Looks Better Positioned for 2026?

Oracle shares surged 87% year-to-date by September 2025, then dropped 30% before stabilizing near $216. Amazon gained 6.8% in 2025, lagging major indexes and trading around $230. Oracle trades at 45–50x earnings, seen as undervalued by some models, while Amazon’s P/E sits in the low-30s, also viewed as modestly undervalued. Oracle’s cloud revenue rose about 25% for the year, with infrastructure up nearly 50%.
5 December 2025
···
Oracle (ORCL) Stock Today: AI Cloud Backlog, Debt Warnings and What to Expect from Dec. 10 Earnings

Oracle (ORCL) Stock Today: AI Cloud Backlog, Debt Warnings and What to Expect from Dec. 10 Earnings

Oracle shares rose to about $217 in late morning trading December 5, up 3% from Wednesday’s close and valuing the company near $610 billion. The move follows renewed optimism over Oracle’s AI-driven cloud strategy ahead of fiscal Q2 earnings on December 10. Analysts expect revenue growth of around 15% and adjusted EPS of $1.64. Oracle’s debt-to-equity stands at roughly 3.3×, with a current ratio near 0.62.
5 December 2025
·····
Oracle Stock on December 5, 2025: AI Cloud Boom, Default Fears and Earnings Countdown for ORCL

Oracle Stock on December 5, 2025: AI Cloud Boom, Default Fears and Earnings Countdown for ORCL

Oracle shares traded near $214 Friday, up 3.2% after analysts raised price targets, but remain about 40% below their 52-week high. The stock dropped 20–23% in November amid rising volatility and credit-default-swap spreads, with Oracle’s 5-year CDS hitting 128 basis points, its highest since the financial crisis. Investors cite concerns over Oracle’s $100 billion debt and aggressive AI infrastructure spending. Q2 FY26 earnings are due December 10.
5 December 2025
····
2025 Gartner Magic Quadrant for Financial Planning Software: Workday, OneStream and Board Front an AI Arms Race in FP&A

2025 Gartner Magic Quadrant for Financial Planning Software: Workday, OneStream and Board Front an AI Arms Race in FP&A

Gartner released its 2025 Magic Quadrant for Financial Planning Software, evaluating 14 vendors including Workday, OneStream, and Board. Within hours, several vendors announced new leadership roles and AI-driven strategies. Workday reported its fourth consecutive year as a Leader, highlighting its focus on agentic AI and unified enterprise planning. Announcements followed December 4–5, 2025.
5 December 2025
········
Oracle Stock on December 4, 2025: AI Backlog, Debt Fears and the High‑Stakes Earnings Ahead

Oracle Stock on December 4, 2025: AI Backlog, Debt Fears and the High‑Stakes Earnings Ahead

Oracle shares rose about 3% to $215 on December 4, 2025, but remain nearly 40% below their 52-week high after a sharp AI-fueled rally and subsequent selloff. Investors are weighing a large AI backlog against rising debt and credit concerns ahead of Oracle’s Q2 2026 earnings report on December 10. Market sentiment has soured, but Deutsche Bank reiterated a Buy rating with a $375 target.
4 December 2025
····
Oracle Stock (ORCL) in December 2025: AI Cloud Supercycle Meets Debt Jitters Ahead of Q2 FY26 Earnings

Oracle Stock (ORCL) in December 2025: AI Cloud Supercycle Meets Debt Jitters Ahead of Q2 FY26 Earnings

Oracle shares closed at $207.73 on December 3, down roughly 35–40% from a September peak above $320 after an AI-driven rally. Fiscal Q1 2026 results showed $14.9 billion in revenue, with cloud revenue up 28% and remaining performance obligations surging to $455 billion. Oracle reports fiscal Q2 earnings on December 10.
4 December 2025
···
Oracle Stock (ORCL) Today: AI Cloud Winner, Wells Fargo Upgrade and Long‑Term Forecasts to 2030

Oracle Stock (ORCL) Today: AI Cloud Winner, Wells Fargo Upgrade and Long‑Term Forecasts to 2030

Oracle shares traded near $204 on December 3 after a volatile month, down about 22% but still up 21% year to date. Wells Fargo initiated coverage at “Overweight,” citing Oracle’s $500 billion AI workload pipeline as a growth driver. Invesco boosted its stake by 42% in Q2, while other funds trimmed holdings. Analyst reports highlight both short-term pressure and long-term optimism tied to Oracle Cloud Infrastructure.
3 December 2025
···
Oracle Stock After the Bell: ORCL Holds the Line Around $201 as Wall Street Splits on Its AI Supercycle – Dec. 1, 2025

Oracle Stock After the Bell: ORCL Holds the Line Around $201 as Wall Street Splits on Its AI Supercycle – Dec. 1, 2025

Oracle shares closed just above $200 on December 1, down 40% from September’s record high near $328. The stock slipped less than half a percent Monday after trading between $196.7 and $203.5 on average volume. The sharp decline follows concerns over AI infrastructure spending and Oracle’s rising debt since its strong fiscal Q1 report in September.
1 December 2025
···
Oracle Stock (ORCL) in December 2025: AI Backlog Jitters vs. $144 Billion Cloud Dream

Oracle Stock (ORCL) in December 2025: AI Backlog Jitters vs. $144 Billion Cloud Dream

Oracle shares closed at $202 on December 1, 2025, down 40% from their 52-week high and among the worst performers in mega-cap tech last month. The sell-off follows concerns over debt-fueled AI spending and exposure to OpenAI. Analysts’ average 12-month target still implies over 60% upside. The company reports fiscal Q2 earnings on December 8.
1 December 2025
···
Oracle Stock Price Forecast 2026: Can AI and Cloud Growth Reignite ORCL After Its 2025 Sell‑Off?

Oracle Stock Price Forecast 2026: Can AI and Cloud Growth Reignite ORCL After Its 2025 Sell‑Off?

Oracle shares trade near $200, down 41% from a 2025 peak after heavy AI and data-center spending triggered a sell-off. Fiscal 2025 revenue reached up to $59 billion with net income over $12 billion, but net debt stands above $100 billion and free cash flow turned negative. Wall Street targets for 2026 vary widely as analysts weigh large AI contracts against high leverage and credit risk.
30 November 2025
··
1 … 7 8 9 10 11 … 14

Stock Market Today

  • SoFi Stock Steady in Premarket Amid Market Caution
    June 10, 2026, 5:38 AM EDT. SoFi Technologies shares held steady near $16.47 in early U.S. premarket trading on June 10, 2026, as investors navigated a cautious market tone. The digital lender, valued at about $22.7 billion, faces pressure from broader risk-off sentiment, particularly in technology stocks. Market watchers awaited crucial U.S. inflation data, which could influence Federal Reserve interest rate decisions. SoFi continues to expand its offerings, recently launching SoFi Coach, an AI-driven financial planning tool, and promoting its stablecoin, SoFiUSD. The fintech's performance serves as a key test amid a volatile environment marked by geopolitical tensions and rising oil prices. This positioning underlines investor sensitivity to growth-linked stocks in a defensive market context.

Latest articles

Micron Stock’s $1 Trillion AI Test Is Here as Traders Look to June 24

Micron Stock’s $1 Trillion AI Test Is Here as Traders Look to June 24

10 June 2026
Micron shares fell 1.5% to $935.89 as the AI-chip rally cooled, despite bullish analyst calls and price targets up to $1,625; investors await the June 24 earnings report to see if tight memory chip supply and AI demand can sustain the stock’s trillion-dollar valuation amid broader market jitters and shifting sentiment.
Ondas Stock Comes Back Into the Spotlight After 13% Drop; Drone Trade Faces Fresh Challenge

Ondas Dips Premarket After 2.7 Million-Share Filing

10 June 2026
SoFi Technologies traded near $16.47 in early premarket, little changed as investors weighed its AI and digital asset product push against a risk-off market mood, with no fresh earnings news and inflation data looming that could impact rates, loan demand, and fintech valuations.
Ondas Dips Premarket After 2.7 Million-Share Filing

SoFi Stock Holds Ahead of Pre-Market Test as Wall Street Grows Defensive

10 June 2026
Rolls-Royce shares rebounded 1.5% in London after Tuesday’s 2.68% drop, as investors weighed fresh airline criticism over engine delays against the company’s reaffirmed 2026 profit and cash flow guidance; CEO Tufan Erginbilgic said Rolls had a “strong start to the year,” but risks remain if airline pressure leads to higher costs or slower cash conversion.
LVMH Drops Following Quick Rally, RBC Still Sees Recovery for Luxury

LVMH Drops Following Quick Rally, RBC Still Sees Recovery for Luxury

10 June 2026
LVMH shares slipped 0.49% to €489.90 in Paris after a four-day rebound, as investors weighed RBC’s reiterated Buy rating with a €600 target against ongoing 2026 losses and a 24% year-to-date drop; all eyes now turn to July’s first-half results for signs of recovery in Fashion & Leather Goods and any relief from Middle East weakness.
Roche Shares Edge Up After $2.3 Billion Nurix Cancer Pact

Roche Shares Edge Up After $2.3 Billion Nurix Cancer Pact

10 June 2026
Roche’s participation certificates climbed 1.07% to CHF 322.20 after announcing a $2.3 billion deal with Nurix Therapeutics for late-stage blood-cancer drug bexobrutideg, planned to enter Phase 3 trials this summer in CLL, as investors weigh the asset’s potential to offset losses from expiring patents and drive mid-single-digit sales growth in 2026.
Go toTop